Clinical Trial Update: Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C

View source ↗

Summary

A Mayo Clinic sponsored clinical trial evaluating monoclonal B-cell lymphocytosis in individuals with chronic hepatitis C has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Monoclonal B-cell Lymphocytosis

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Viral Hepatitis C, Monoclonal B-Cell Lymphocytosis | Status: TERMINATED